SBMJF
DIMERIX BIOSCIENCE LTD by Dimerix Bioscience Ltd (SBMJF)
$25
About DIMERIX BIOSCIENCE LTD by Dimerix Bioscience Ltd (SBMJF)
Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. It focuses on the development of Dimerix DMX-200 drug candidate in both renal and respiratory indications and the development of Dimerix DMX-700 pre-clinical asset in Chronic Obstructive Pulmonary Disease. The company was founded on May 13, 1975 and is headquartered in Melbourne, Australia.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.29
52 Week Low
$0.25
Market cap
139.8M
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
-8.50
DIMERIX BIOSCIENCE LTD by Dimerix Bioscience Ltd News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.29
52 Week Low
$0.25
Market cap
139.8M
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
-8.50